LUCD
Lucid Diagnostics Inc
0.6273$
-1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,121.5% | -959.5% | -1,259.9% | -1,176.4% | -868.2% | -824.6% | -1,505.4% | -907.1% | -899.5% | -836.3% | -963.5% | -766.4% | -860.8% | |
| 79.8% | 60.5% | 50.0% | 23.5% | 18.3% | 18.5% | 26.7% | 19.1% | 18.2% | 28,509.3% | 17.7% | 15.2% | 7,887.0% | |
| 159.9% | 92.6% | 93.1% | 123.3% | 104.8% | 97.8% | 124.4% | 98.4% | 95.1% | 152,516.5% | 112.3% | 115.5% | 42,205.9% | |
| 64.2% | -19.3% | -332.9% | -196.1% | -11.9% | 79.7% | -164.3% | -61.0% | -57.1% | -3.0% | -136.4% | -34.9% | -54.5% | |
| 1.8% | 16.8% | 3.7% | 0.0% | 29.9% | 21.6% | 11.2% | 2.1% | 2.3% | 3.4% | 17.1% | 1.4% | 5.8% | |
| -1.8% | -16.8% | -3.7% | – | -29.9% | -21.6% | -11.2% | -2.1% | -2.3% | -3.4% | -17.1% | -1.4% | -5.8% | |
| – | 26,442.3% | 35,264.7% | – | 8,020.5% | – | 17,029.0% | 0.0% | 22,460.8% | 8,710.1% | 16,719.7% | 14,246.9% | 15,114.8% | |
| – | – | – | – | 0.0% | 1,503.7% | 43.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 35.1% | 480.8% | 1,850.3% | 1,191.9% | 8.0% | 1,503.7% | 1,864.5% | 1,415.2% | 2,240.3% | 0.1% | 436.9% | 1,142.9% | 908.4% | |
| -1,088.1% | -495.6% | 586.7% | 15.5% | -890.0% | 657.4% | 347.8% | 506.0% | 1,338.5% | -839.6% | -543.7% | 375.0% | 41.9% | |
| -1,123.2% | -976.3% | -1,263.6% | -1,176.4% | -898.0% | -846.3% | -1,516.7% | -909.2% | -901.8% | -839.7% | -980.6% | -767.8% | -866.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.